Case series of low dose rituximab for membranous nephropathy; a single centre experience by Gerry George Mathew, Jayaprakash Varadharajan, Sreedhar Sailapathy

Subjects: Get full text

Evans syndrome: clinical perspectives, biological insights and treatment modalities by Jaime-Pérez JC, Aguilar-Calderón PE, Salazar-Cavazos L, Gómez-Almaguer D

Subjects: Get full text

Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody by Ying Hou, Chao Zhang, Xiaolin Yu, Xiaolin Yu, Wenqing Wang, Dong Zhang, Yunfei Bai, Chuanzhu Yan, Chuanzhu Yan, Chuanzhu Yan, Lin Ma, Lin Ma, Anning Li, Jian Ji, Lili Cao, Qinzhou Wang

Subjects: Get full text

Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabin... by Dena R Howard, Talha Munir, Lucy McParland, Andy C Rawstron, Anna Chalmers, Walter M Gregory, John L O’Dwyer, Alison Smith, Roberta Longo, Abraham Varghese, Alexandra Smith, Peter Hillmen

Subjects: “…fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab…”
Get full text